Mesoblast Partners With Cartherics to Develop ’off-the-shelf’ Cell-based Immunotherapies for Solid Cancers Genetics Investing
“Avitas CBD Water, LLC” Rebranded As “Xanthic Beverages” and First Production to be Distributed to Over 500 Retail Locations Biotech Investing
Isodiol International Inc. Announces Closing of Strategic Non-Brokered Offering for Total Proceeds of $18 Million Cannabis Investing News
IMFINZI (Durvalumab) Significantly Improves Overall Survival in the Phase III Pacific Trial for Unresectable Stage III Non-Small Cell Lung Cancer Pharmaceutical Investing
Oncolytics Biotech Announces Research Collaboration with the Keck School of Medicine of USC Combining REOLYSIN with Keytruda, Velcade and Dexamethasone Biotech Investing
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026
